Cargando…

Meta-analysis of outcomes from drug-eluting stent implantation in femoropopliteal arteries

OBJECTIVE: In recent years, studies of drug-eluting stent (DES) for femoropopliteal artery diseases (FPADs) have been gradually published. To explore whether this type of stent is superior to the traditional bare metal stent (BMS), we performed this study. METHODS: A systematic search for randomized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingxuan, Tu, Haixia, Yan, Yu, Guo, Zhen, Zhu, Haitao, Niu, Jiangliang, Yin, Mengchen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513203/ https://www.ncbi.nlm.nih.gov/pubmed/37733656 http://dx.doi.org/10.1371/journal.pone.0291466

Ejemplares similares

Meta-analysis of outcomes from drug-eluting stent implantation in infrapopliteal arteries
por: Li, Ming-Xuan, et al.
Publicado: (2023)

Impact of postprocedural minimum lumen area on clinical outcome after femoropopliteal drug-eluting stent implantation
por: Haraguchi, Takuya, et al.
Publicado: (2023)

Calcified nodule progression-related stent thrombosis after polymer-based paclitaxel-eluting nitinol stent implantation for femoropopliteal artery
por: Nakama, Tatsuya, et al.
Publicado: (2020)

Prophylactic paclitaxel-eluting stent placement does not improve covered femoropopliteal stent patency()
por: Marples, Rory, et al.
Publicado: (2021)

Long coverage with drug-eluting stents is superior to spot coverage for long femoropopliteal artery disease: PARADE II study
por: Park, Jong-Il, et al.
Publicado: (2022)

Drug‐Coated Balloon and Drug‐Eluting Stent Safety in Patients With Femoropopliteal and Severe Chronic Kidney Disease
por: Hanna, Jonathan, et al.
Publicado: (2023)

Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
por: Katsanos, Konstantinos, et al.
Publicado: (2016)

A Budget Impact Model for Paclitaxel-eluting Stent in Femoropopliteal Disease in France
por: De Cock, Erwin, et al.
Publicado: (2012)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Histological Evaluation of Self-Expandable Interwoven Stent After Implantation in the Femoropopliteal Artery
por: Hata, Yosuke, et al.
Publicado: (2020)

Emerging Stent and Balloon Technologies in the Femoropopliteal Arteries
por: Pastromas, Georgios, et al.
Publicado: (2014)

Comparison of efficacy and safety of drug-eluting versus uncoated balloon angioplasty for femoropopliteal arterial occlusive disease: a meta-analysis
por: Feng, Hai, et al.
Publicado: (2020)

Angiographic and Intravascular Imaging Findings for Ultrasound Detected Aneurysmal Degeneration Following Polymer Based Paclitaxel Eluting Nitinol Stent Implantation for Femoropopliteal Artery Occlusion
por: Nakama, Tatsuya, et al.
Publicado: (2020)

Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
por: Dake, Michael D., et al.
Publicado: (2016)

Widowmaker Right Coronary Artery Treated With Drug-Eluting Stent Implantation
por: Singh, Gurpreet, et al.
Publicado: (2019)

Polymer-free drug-eluting stents versus permanent polymer drug-eluting stents: An updated meta-analysis
por: Chen, Yun-lin, et al.
Publicado: (2019)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Coronary Artery Aneurysm after Second-Generation Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2019)

Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
por: Kichikawa, Kimihiko, et al.
Publicado: (2018)

Bare metal stent versus paclitaxel eluting stent for intermediate length femoropopliteal arterial lesions (BATTLE trial): study protocol for a randomized controlled trial
por: Gouëffic, Yann, et al.
Publicado: (2014)

Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
por: Wang, Guozhong, et al.
Publicado: (2019)

Clinical Outcomes of Drug-Eluting versus Bare-Metal In-Stent Restenosis after the Treatment of Drug-Eluting Stent or Drug-Eluting Balloon: A Systematic Review and Meta-Analysis
por: Yang, Yi-Xing, et al.
Publicado: (2020)

The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)

Case series of coronary artery aneurysms after Everolimus eluting stent implantation and comparison with Sirolimus eluting stents
por: Sharma, Raghav, et al.
Publicado: (2022)

Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease
por: Müller-Hülsbeck, Stefan, et al.
Publicado: (2016)

Ten-Year Clinical Follow-Up Following Bare-Nitinol Stent Implantation for Femoropopliteal Artery Disease
por: Soga, Yoshimitsu, et al.
Publicado: (2022)

Heterogeneous vascular response after implantation of bare nitinol self-expanding stents in the swine femoropopliteal artery
por: Kawarada, Osami, et al.
Publicado: (2022)

Trans-stent graft thrombectomy for the treatment of long stent graft thrombosis in the femoropopliteal artery
por: Ozawa, Hirotsugu, et al.
Publicado: (2021)

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis
por: Bangalore, Sripal, et al.
Publicado: (2013)

Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis
por: Yin, Juntao, et al.
Publicado: (2023)

Value of M2BP in predicting in‐stent restenosis in patients after coronary drug‐eluting stent implantation
por: Yang, Le, et al.
Publicado: (2022)

Importance to Know the Long-Term Outcome after Endovascular Therapy with Bare Metal Stent Implantation for Femoropopliteal Artery Disease
por: Ito, Naruhiko
Publicado: (2022)

Drug-Coated Balloon for the Treatment of Femoropopliteal Tosaka Class III In-stent Restenosis Lesions
por: Zhang, Bihui, et al.
Publicado: (2021)

Drug-Eluting Stent Fracture within 6 Days after Stent Implantation
por: Zamany, J, et al.
Publicado: (2011)

Predictors of diffuse-type in-stent restenosis following drug-eluting stent implantation
por: PARK, CHANG-BUM, et al.
Publicado: (2013)

Drug-eluting stents in the management of peripheral arterial disease
por: Bosiers, Marc, et al.
Publicado: (2008)

Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms
por: Cui, Yuanyuan, et al.
Publicado: (2016)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

In-Stent Restenosis due to Stent Recoil After Third-Generation Drug-Eluting Stent Implantation
por: Kato, Yuta, et al.
Publicado: (2017)

Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation
por: Ishihara, Takayuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9l76td8btcp6ipqbna4ah8hda9